Stocks and Investing
Stocks and Investing
Mon, April 15, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Burns Reiterated (ADCT) at Strong Buy and Held Target at $9 on, Apr 15th, 2024
Robert Burns of HC Wainwright & Co., Reiterated "ADC Therapeutics SA" (ADCT) at Strong Buy and Held Target at $9 on, Apr 15th, 2024.
Robert has made no other calls on ADCT in the last 4 months.
There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 0 agree with Robert's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Robert
- Michael Schmidt of "Guggenheim" Reiterated at Strong Buy on, Friday, April 5th, 2024
- Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $8 on, Thursday, March 14th, 2024
Contributing Sources